Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Pharmacodynamic Effects of Dorzagliatin in Pancreatic Insufficient-Cystic Fibrosis: A Randomized Double-blind, Cross-over Trial

NCT06995651 is registered in ClinicalTrials.gov with Michael R. Rickels, MD, MS as lead sponsor.

NCT NCT06995651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06995651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Pharmacodynamic Effects of Dorzagliatin in Pancreatic Insufficient-Cystic Fibrosis: A Randomized Double-blind, Cross-over Trial
Lead sponsor
Michael R. Rickels, MD, MS
Phase
Phase 1
Overall status
Recruiting
Start date
October 21, 2025
Completion date
July 31, 2027
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis-related diabetes, pancreatic insufficiency